| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/09/2010 | US20100226987 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers |
| 09/09/2010 | US20100226986 Therapeutic Particles Suitable for Parenteral Administration and Methods of Making and Using Same |
| 09/09/2010 | US20100226985 Viscoelastic aqueous gels comprising microspheres |
| 09/09/2010 | US20100226984 Molecular recognition matrix and method for making same |
| 09/09/2010 | US20100226983 Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof |
| 09/09/2010 | US20100226982 Stabilized Active Ingredient Composition |
| 09/09/2010 | US20100226981 Oral dosage forms having a high loading of a gabapentin prodrug |
| 09/09/2010 | US20100226980 Novel tablet based on s-adenosyl-methionine |
| 09/09/2010 | US20100226979 Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate |
| 09/09/2010 | US20100226978 Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
| 09/09/2010 | US20100226977 Low viscosity phospholipid compositions |
| 09/09/2010 | US20100226976 Encapsulated mesenchymal stem cells and uses thereof |
| 09/09/2010 | US20100226975 Compositions and Methods for Stabilizing Lipid Based Adjuvant Formulations Using Glycolipids |
| 09/09/2010 | US20100226974 Antibody recognizing antigen |
| 09/09/2010 | US20100226973 Methods and compositions for liposomal formulation of antigens and uses thereof |
| 09/09/2010 | US20100226972 Transdermal pain gel |
| 09/09/2010 | US20100226971 Ultrasound-enhanced intrascleral delivery of macromolecules |
| 09/09/2010 | US20100226970 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 09/09/2010 | US20100226969 Compounds for inhibiting protein aggregation, and methods for making and using them |
| 09/09/2010 | US20100226968 Topical agent for muscle treatment |
| 09/09/2010 | US20100226967 Imaging and therapeutic method using progenitor cells |
| 09/09/2010 | US20100226966 Method for transdermal controlled release drug delivery |
| 09/09/2010 | US20100226965 Compositions & methods for wound healing |
| 09/09/2010 | US20100226964 Highly Compactable and durable direct compression excipients and excipient systems |
| 09/09/2010 | US20100226963 Bi-functional co-polymer use for opthalmic and other topical and local applications |
| 09/09/2010 | US20100226961 Cross-linked bioactive hydrogel matrices |
| 09/09/2010 | US20100226957 Protein-Based Artificial Retinas |
| 09/09/2010 | US20100226956 Production of moldable bone substitute |
| 09/09/2010 | US20100226955 Polymer for creating hemocompatible surface |
| 09/09/2010 | US20100226954 Polymeric delivery formulations of leuprolide with improved efficacy |
| 09/09/2010 | US20100226948 Methods and compositions for treating acne |
| 09/09/2010 | US20100226947 Articles of manufacture releasing an active ingredient |
| 09/09/2010 | US20100226945 Dye-free pharmaceutical suspensions and related methods |
| 09/09/2010 | US20100226944 Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process |
| 09/09/2010 | US20100226943 Surface topographies for non-toxic bioadhesion control |
| 09/09/2010 | US20100226941 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides |
| 09/09/2010 | US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides |
| 09/09/2010 | US20100226863 Homeopathic medicament useful for immunomodulation |
| 09/09/2010 | US20100226862 Microcapsule and method for magnetic resonance imaging to localize blood |
| 09/09/2010 | US20100226856 Dynamic bio-nanoparticle elements |
| 09/09/2010 | US20100226855 Rate-Controlled Oral Dosage Formulations |
| 09/09/2010 | US20100224042 Method and device for producing small, thin sheets from an active-ingredient film |
| 09/09/2010 | DE202010007560U1 Mehrschichtige Einbettungsstruktur, geeignet zum Einbetten von probiotikahaltigen Aktivmittel-Teilchen Multi-layer embedding structure, suitable for embedding probiotikahaltigen active agent particles |
| 09/09/2010 | DE102009012069A1 Verfahren zur Herstellung von Kosmetika Process for the preparation of cosmetics |
| 09/09/2010 | DE102009012068A1 Preparing a cosmetic or pharmaceutical product e.g. shampoo and lipstick, comprises spraying a component in liquid state, cooling in shock-like manner and converting into granules, and processing the granules with other components |
| 09/09/2010 | DE102009001334A1 Multiple capsule, useful for oral administration of gastric fluid sensitive substance and treating e.g. inflammatory diseases e.g. pure arthritis in human, dog or cat, comprises two capsules nested within each other on its cylindrical part |
| 09/09/2010 | CA2696213A1 Tolperisone controlled release tablet |
| 09/08/2010 | EP2226085A1 Anti-angiogenic compositions and methods of use |
| 09/08/2010 | EP2226083A1 Drug delivery system |
| 09/08/2010 | EP2226069A1 Edible film |
| 09/08/2010 | EP2226043A1 Implantable fluid delivery apparatuses and implantable electrode |
| 09/08/2010 | EP2225270A1 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression |
| 09/08/2010 | EP2225262A2 Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 09/08/2010 | EP2224960A2 Method of treating cancer |
| 09/08/2010 | EP2224950A1 Medicament for the treatment of cancer of the pancreas |
| 09/08/2010 | EP2224914A2 Rhein or diacerein compositions |
| 09/08/2010 | EP2224913A1 Improved formulations and methods for lyophilization and lyophilates provided thereby |
| 09/08/2010 | EP2224912A1 Improved compositions and methods for the delivery of nucleic acids |
| 09/08/2010 | EP2224910A1 Rinse solution |
| 09/08/2010 | EP2224909A1 Stabilisation of liquid-formulated factor vii(a) polypeptides by aldehyde-containing compounds |
| 09/08/2010 | EP2224908A2 Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent, methods for preparing same and uses thereof |
| 09/08/2010 | EP2224907A1 Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispersing agent and method for the preparation thereof |
| 09/08/2010 | EP2224906A1 A method for producing adapalene gels |
| 09/08/2010 | EP2224904A2 Intravesical compositions with valrubicin for the treatment of bladder cancer |
| 09/08/2010 | EP2224820A1 Comestible products |
| 09/08/2010 | EP2224815A1 Silver nanoparticles with specific surface area and a method for producing them |
| 09/08/2010 | EP2224808A2 Pharmaceutical composition |
| 09/08/2010 | EP2224805A1 Pharmaceutical composition |
| 09/08/2010 | EP2139503B1 Cosmetic and dermatological compositions based on algae extracts |
| 09/08/2010 | EP1917005B1 Device, system, and method comprising microencapsulated proton donor for release of nitric oxide from a polymer |
| 09/08/2010 | EP1713468B9 Anthelmintic composition |
| 09/08/2010 | EP1696960B1 Intranasal administration of glucose-regulating peptides |
| 09/08/2010 | EP1638524B1 Composition and method for the treatment of water related ear disorders |
| 09/08/2010 | EP1590006B1 Ultrasound contrast agents and process for the preparation thereof |
| 09/08/2010 | EP1572230B1 Placental alkaline phosphatase to control diabetes |
| 09/08/2010 | EP1399190B1 Pharmaceutical compositions comprising low-solubility and acid-sensitive drugs and neutralized acidic polymers |
| 09/08/2010 | EP1388340B1 Compositions for transmucosal administration containing coenzyme q as the active ingredient |
| 09/08/2010 | EP1347787B2 Use of dexpanthenol in contact lens care compositions |
| 09/08/2010 | EP0981373B2 Biofunctional polymers prepared in supercritical fluid |
| 09/08/2010 | CN201572342U Acupoint hypotensive paste |
| 09/08/2010 | CN201572341U Compound amlodipine besylate atorvastatin calcium tablet |
| 09/08/2010 | CN201572340U Patch capable of adding medicine |
| 09/08/2010 | CN1997362B Chewable, suckable and swallowable tablet containing a caicium-containing compound as an active substance |
| 09/08/2010 | CN1973853B Hemostatic and analgetic medicine composition and its preparation process |
| 09/08/2010 | CN1970035B Formulation of 'Sheng Mai', preparation process and quality control method thereof |
| 09/08/2010 | CN1970025B Chinese medicinal biological agent of 'Liu Wei Di Huang' decoction and preparation process thereof |
| 09/08/2010 | CN1965885B Application of total flavones of chickpea in preparation of medicament for treating diabetes |
| 09/08/2010 | CN1958024B Chinese traditional medicine for treating coronary heart disease, angina pectoris, and preparation |
| 09/08/2010 | CN1958007B Vagina tablet for treating cervicitis, cervical erosion, and preparation method |
| 09/08/2010 | CN1951424B Pharmaceutical composition for treating gynecological inflammation and preparation method thereof |
| 09/08/2010 | CN1943773B A Chinese traditional medicinal composition and its preparation methods |
| 09/08/2010 | CN1943642B Preparing method for a kind of medicinal composition and its effective parts and active ingredients |
| 09/08/2010 | CN1939533B Injection sarcosine peptide aglycone powdery injection and its making method |
| 09/08/2010 | CN1939462B Health-care Chinese medicinal preparation with anti senility function |
| 09/08/2010 | CN1935201B Radix aconiti carmichaeli extract and its preparing method |
| 09/08/2010 | CN1931268B Acne treating medicine |
| 09/08/2010 | CN1931260B Hyperlipemia treating oral liquid |
| 09/08/2010 | CN1915221B Liposome of alkaloid in vinca, and preparation method |
| 09/08/2010 | CN1913905B Probiotic tablet formulations |
| 09/08/2010 | CN1907327B Medicine composition for treating cardiovascular and cerebrovascular diseases caused by qi stagnation blood stasis, preparation method and application thereof |